Position in GRAL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,794,329
-$5,509,009 QoQ
Shares Held
70,226
-64.8% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#51
of 374 holders
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NATIXIS holds $242,316,075 across 12 Diagnostics & Research names. GRAL ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
241,128 | $120,891,934 | |
| 2 | DHR |
Danaher Corp /De/
|
381,030 | $72,578,594 | |
| 3 | LH |
Labcorp Holdings Inc.
|
53,983 | $15,115,240 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
14,565 | $7,667,598 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
5,315 | $6,789,965 | |
| 6 | GRAL |
GRAIL, Inc.
This page
|
70,226 | $4,794,329 | |
| 7 | DGX |
Quest Diagnostics Inc
|
21,866 | $4,634,498 | |
| 8 | A |
Agilent Technologies, Inc.
|
32,579 | $4,327,468 |
All Filings in GRAL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,794,329 | 70,226 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,303,338 | 199,368 | Shares | Sole | 2026-05-14 | |
| 2024-06-30 | $512,435 | 33,340 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||